Annals of Surgical Oncology

, Volume 6, Issue 7, pp 671–675

Feasibility of Immediate Breast Reconstruction for Locally Advanced Breast Cancer

  • Lisa A. Newman
  • Henry M. Kuerer
  • Kelly K. Hunt
  • Frederick C. Ames
  • Merrick I. Ross
  • Richard Theriault
  • Nancy Fry
  • Stephen S. Kroll
  • Geoffrey L. Robb
  • S. Eva Singletary
Original Article


Background: Immediate breast reconstruction (IBR) has been considered contraindicated for patients with locally advanced breast cancer (LABC). Our goal was to determine whether IBR resulted in delayed postoperative chemotherapy, increased postoperative complications, or increased risk of recurrent disease.

Methods: A prospective database of 540 modified radical mastectomies performed with IBR between 1990 and 1993 identified 50 patients with LABC. Postoperative management and outcome were compared to that of 72 patients undergoing modified radical mastectomy without IBR treated on a standardized LABC protocol using preoperative chemotherapy, postoperative chemotherapy, and radiotherapy during the same time period.

Results: Results were evaluated by χ2 analysis. The median ages for the patients with IBR versus those not undergoing IBR were 44 and 46 years, respectively. The stage distribution for the IBR patients versus patients not undergoing IBR was as follows: IIB, 46% versus 17%; IIIA, 44% versus 39%; and IIIB, 10% versus 44%. The types of IBR were transverse rectus abdominis myocutaneous (TRAM) flap (68%), latissimus dorsi flap (2%), and implants (30%). Chemotherapy was given to all IBR patients: 24% preoperatively and 96% postoperatively. Radiotherapy was used in 40%. Four postoperative complications (8%) necessitated prolongation of hospitalization, including two patients requiring surgical debridement for partial flap loss; there were no complete flap losses. The incidences of major and minor wound complications in the group not undergoing IBR were 7% and 4%, respectively. Of the 15 patients receiving implant reconstruction, 7 (47%) required subsequent implant removal because of contractures or infections. The median interval between surgery and postoperative chemotherapy was 35 days for the IBR patients and 21 days for the patients not undergoing IBR. This difference was marginally significant (P 5.05). With a median follow-up of 58.4 months, no significant differences in local or distant relapse rates were detected.

Conclusions: IBR can be performed with low morbidity in patients with LABC. Use of autogenous tissue is preferable because of poor results with implants. IBR is associated with somewhat longer intervals to resumption of postoperative chemotherapy, but this does not appear to be clinically significant—the local and distant relapse rates are similar for LABC patients undergoing modified radical mastectomy with or without IBR.

Key Words

Locally advanced breast cancer Immediate breast reconstruction 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Slavin SA, Love SM, Goldwyn RM. 1994 Recurrent breast cancer following immediate reconstruction with myocutaneous flaps. Plast Reconstr Surg 93:1191–1204.PubMedGoogle Scholar
  2. 2.
    Sultan MR, Smith ML, Estabrook A, Schnabel F, Singh D. 1997 Immediate breast reconstruction in patients with locally advanced disease. Ann Plast Surg 38:345–351.PubMedGoogle Scholar
  3. 3.
    Styblo TM, Lewis MM, Carlson GW, et al. 1996 Immediate breast reconstruction for Stage III breast cancer using transverse rectus abdominis musculocutaneous (TRAM) flap. Ann Surg Oncol 3:375–380.PubMedGoogle Scholar
  4. 4.
    Godfrey PM, Godfrey NV, Romita MC. 1995 Immediate autogenous breast reconstruction in clinically advanced disease. Plast Reconstr Surg 95:1039–1044.PubMedGoogle Scholar
  5. 5.
    Wey PD, Highstein JB, Borah GL. 1997 Immediate breast reconstruction in the high-risk setting. Ann Plast Surg 38:342–344.PubMedGoogle Scholar
  6. 6.
    Steele GD, Osteen RT, Winchester DP, eds. 1994 National Cancer Data Base Annual Review of Patient Care, 1994. American Cancer Society: ChicagoGoogle Scholar
  7. 7.
    Hortobagyi GN, Singletary SE, McNeese MD. 1996 Treatment of locally advanced and inflammatory breast cancer. In: Harris JR, Lippman ME, Morrow M, Hellman S, eds. Diseases of the Breast. Lippincott-Raven Philadelphia 585–599.Google Scholar
  8. 8.
    Kuerer HM, Newman LA, Smith TL, et al. 1999 Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy. J Clin Oncol 17:460–469.PubMedGoogle Scholar
  9. 9.
    Johnson CH, Van Heerden JA, Donohue JH. 1989 Oncological aspects of immediate breast reconstruction following mastectomy for maligancy. Arch Surg 124:819–823.PubMedGoogle Scholar
  10. 10.
    Patel RJ, Webster DJT, Mansel RE, Hughes LE. 1993 Is immediate postmastectomy reconstruction safe in the long-term? Eur J Surg Oncol 19:372–375.PubMedGoogle Scholar
  11. 11.
    Noone RB, Frazier TG, Noone GC, Blanchet NP, Murphy JB, Rose D. 1994 Recurrence of breast carcinoma following immediate reconstruction: A 13-year review. Plast Reconstr Surg 93:96–108.PubMedCrossRefGoogle Scholar
  12. 12.
    Eberlein TJ, Crespo LD, Smith BL, Hergrueter CA, Douville L, Eriksson E. 1993 Prospective evaluation of immediate breast reconstruction after mastectomy. Ann Surg 218:29–36.PubMedGoogle Scholar
  13. 13.
    Worseg A, Kuzbari R, Tairch G. 1995 Long-term results of inflatable mammary implants. Br J Plast Surg 48:183– 188.PubMedGoogle Scholar
  14. 14.
    Mandrekas AD, Zambacos GJ, Katsanton PN. 1995 Immediate and delayed breast reconstruction with permanent tissue expanders. Br J Plast Surg 48:572–578.PubMedGoogle Scholar
  15. 15.
    Schusterman MA, Kroll SS, Miller MJ. 1994 The free transverse rectus abdominis musculocutaneous flap for breast reconstruction: one center’s experience with 211 consecutive cases. Ann Plast Surg 32:234–242.PubMedGoogle Scholar
  16. 16.
    Watterson PA, Bostwick J II, Hester TR Jr. 1995 TRAM flap anatomy correlated with a ten-year clinical experience with 556 patients. Plast Reconstr Surg 95:1185–1194.PubMedGoogle Scholar
  17. 17.
    Buzdar AU, Smith TL, Powell KC, Blumenschein GR, Gehan EA. 1982 Effect of timing of initiation of adjuvant chemotherapy on diseasefree survival in breast cancer. Breast Cancer Res Treat 2: 163–169.PubMedGoogle Scholar
  18. 18.
    Hunt KK, Baldwin BJ, Strom EA, Ames FC, McNeese MD, Kroll SS, Singletary SE. 1997 Feasibility of postmastectomy radiation therapy after TRAM flap breast reconstruction. Ann Surg Oncol 4: 377–384.PubMedGoogle Scholar
  19. 19.
    Halpern J, McNeese MD, Kroll SS, Ellerbroek N. 1990 Irradiation of prosthetically augmented breasts: A retrospective study on toxicity and cosmetic results. Int J Radiat Oncol Biol Phys 18:189.PubMedGoogle Scholar
  20. 20.
    Hartrampf CR, Bennett GK. 1987 Autogenous tissue reconstruction in the mastectomy patient. Ann Surg 205:508–519.PubMedGoogle Scholar
  21. 21.
    Kroll SS, Schusterman MA, Reece GP, Miller MJ, Smith B. 1994 Breast reconstruction with myocutaneous flaps in previously irradiated patients. Plast Reconstr Surg 93:460–469.CrossRefPubMedGoogle Scholar
  22. 22.
    Watterson PA, Bostwick J, Hester TR, Bried JT, Taylor GI. 1995 TRAM flap anatomy correlated with a ten year clinical experience with 556 patients. Plast Reconstr Surg 95:1185–1194.PubMedGoogle Scholar
  23. 23.
    Williams JK, Bostwick J III, Bried JT, Mackay G, Landry J, Benton J. 1995 TRAM flap breast reconstruction after radiation treatment. Ann Surg 221:756–766.PubMedGoogle Scholar
  24. 24.
    Williams JK, Carlson GW, Bostwick J III, Bried JT, Mackay G. 1997 The effects of radiation treatment after TRAM flap econstruction. Plast Reconstr Surg 100:1153–1160.PubMedGoogle Scholar
  25. 25.
    Kraemer O, Anderson M, Siim E. 1996 Breast reconstruction and tissue expansion in irradiated versus not irradiated women after mastectomy. Scand J Plast Reconstr Surg 30:201–206.Google Scholar
  26. 26.
    Victor SJ, Brown DM, Horwitz DM, et al. 1998 Treatment outcome with radiation therapy after breast augmentation or reconstruction in patients with primary breast carcinoma. Cancer 82:1303–1309.PubMedGoogle Scholar
  27. 27.
    Schuster RH, Kuske RR, Young VL, Fineberg B. 1994 Breast reconstruction in women treated with radiation therapy for breast cancer: cosmesis, complications, and tumor control. Plast Reconstr Surg 93:1191–1204.CrossRefGoogle Scholar
  28. 28.
    Dickson MG, Sharpe DT. 1987 The complications of tissue expansion in breast reconstruction: a review of 75 cases. Br J Plast Surg 40:629–635.PubMedGoogle Scholar

Copyright information

© The Society of Surgical Oncology, Inc. 1999

Authors and Affiliations

  • Lisa A. Newman
    • 1
  • Henry M. Kuerer
    • 4
  • Kelly K. Hunt
    • 1
  • Frederick C. Ames
    • 1
  • Merrick I. Ross
    • 1
  • Richard Theriault
    • 2
  • Nancy Fry
    • 2
  • Stephen S. Kroll
    • 3
  • Geoffrey L. Robb
    • 3
  • S. Eva Singletary
    • 1
    • 5
  1. 1.Surgical OncologySan Francisco
  2. 2.Medical Breast OncologySan Francisco
  3. 3.Plastic and Reconstructive SurgeryThe University of Texas M. D. Anderson Cancer CenterHouston
  4. 4.Department of SurgeryUniversity of California San FranciscoSan Francisco
  5. 5.Dept. of Surgical OncologyThe University of Texas M. D. Anderson Cancer CenterHouston

Personalised recommendations